Sat.Dec 31, 2022 - Fri.Jan 06, 2023

article thumbnail

Google and DeepMind share work on medical chatbot Med-PaLM

Pharma Phorum

Google and DeepMind have developed an artificial intelligence-powered chatbot tool called Med-PaLM designed to generate “safe and helpful answers” to questions posed by healthcare professionals and patients.

136
136
article thumbnail

Speech Therapy May Effectively Address Long COVID Communication Issues

Pharmacy Times

In addition to the physical symptoms of long COVID, patients have reported vocal, verbal, and cognitive issues that disrupt their ability to communicate.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Forks in the road lead one medical expert to a ‘game changing’ liver treatment

PharmaVoice

Durect’s chief medical officer altered his retirement plans to take a leading role at the company, which is developing a treatment for severe alcohol-associated hepatitis

111
111
article thumbnail

Type 1 Diabetes: A Potential Cure

PharmExec

One company pursues a program for a technology they believe is a potential cure for Type 1 diabetes.

105
105
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.

article thumbnail

UK partners with BioNTech on clinical trials of mRNA cancer therapies

Pharma Phorum

The UK has formed an partnership with German biotech BioNTech to provide up to 10,000 patients with access to personalised cancer therapies, in another example of the country embracing the mRNA technologies that underpinned COVID-19 vaccines.

Vaccines 111
article thumbnail

Hemophilia B Gene Therapy Significantly Reduces Annual Bleeds in Phase 3 Trial

Pharmacy Times

The FDA granted fidanacogene elaparvovec breakthrough, regenerative medicines advance therapy, and orphan drug designations.

FDA 152

More Trending

article thumbnail

Q&A with Kelly Baker, CFO of Eversana

PharmExec

Baker spoke on topics ranging from pricing, access, the war for talent, and other key areas that are impacting pharma companies.

105
105
article thumbnail

6 research and development life sciences predictions for 2023

Pharma Phorum

From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables life sciences teams to collaborate efficiently and effectively in 2023.

article thumbnail

Improved Access to Direct-acting Antivirals Lowers Hepatitis C Incidence Rates

Pharmacy Times

Study finds a strong decline in hepatitis C incidence in the years immediately following broad access to direct-acting antiviral drugs.

149
149
article thumbnail

Lilly, Biogen, Eisai brace for Alzheimer’s boom or bust in 2023

PharmaVoice

As controversies abound and new drugs rise on the regulatory horizon, this year will be big for Alzheimer’s

98
article thumbnail

State of Financing Deals and Go-to-Market Strategy in Biotech: Q&A with Timothy Moore and Jack Mycka, Indegene

PharmExec

A chat with with Indegene's Timothy Moore, Senior Vice President, Emerging Biotech and Key Accounts and Jack Mycka, Vice President, Enterprise Medical Solutions and Emerging Biotech.

98
article thumbnail

Why script-to-dispense conversion will take centre stage in 2023

Pharma Phorum

With the US economy teetering on a recession, sales and marketing budgets are expected to take a hit among businesses across sectors. The pharmaceutical industry is no exception.

article thumbnail

Promising RSV Vaccine Candidate Raises Hopes

Pharmacy Times

Pharmacists should educate patients about managing respiratory syncytial virus and let them know they may soon be able to get vaccinated.

Vaccines 149
article thumbnail

A new mission in menopause — extending the lives of women

PharmaVoice

Why Evernow CEO Alicia Jackson thinks menopause is the perfect inroad to helping women live longer lives

98
article thumbnail

How Market Access Can Determine Commercial Success

PharmExec

Using market access data from day one of your drug development and commercialization journey puts your brand in the best position to succeed at launch.

98
article thumbnail

It’s time for more tech and biotech innovation in 2023

Pharma Phorum

The drive to make the UK a ‘scientific powerhouse’ was central to the government’s announcement closing out 2022 , which appointed five industry experts to lead on the sectors most vital to UK’s future innovation.

Hospitals 105
article thumbnail

Immunizing Older Individuals Requires Flexibility, Nuance

Pharmacy Times

When it comes to vaccination efforts, remember that patients 65 years or older are not a homogeneous group.

article thumbnail

How mental health made the 'remarkable transition' to virtual: study

Fierce Healthcare

How mental health made the 'remarkable transition' to virtual: study. fdiamond. Thu, 01/05/2023 - 15:21

140
140
article thumbnail

2023 Fundraising Challenges

NF2 BioSolutions

We are doing 2 fundraising challenges throughout the year this year and you can partake in any whenever you like, get everyone involved from mums, dads, kids, grandparents, aunts, uncles, neighbours, friends and work colleagues. HAVE FUN AND RAISE FUNDS FOR NF2 RESEARCH! CAKE BAKE & COFFEE.

article thumbnail

Newron says pivotal treatment-resistant schizophrenia trial is a go

Pharma Phorum

Encouraged by new data, Newron Pharmaceuticals has said it will start a registration study of would-be blockbuster evenamide in treatment-resistant schizophrenia (TRS) later this year.

Labelling 105
article thumbnail

FDA Grants Accelerated Approval to Lecanemab for Early Stage Alzheimer Disease

Pharmacy Times

Lecanemab (Lequembi) approved to treat mild cognitive impairment or mild dementia associated with Alzheimer disease.

FDA 139
article thumbnail

The 2023 PharmaVoice Crystal Ball: Peering into the future of life sciences

PharmaVoice

A preview of the top trends on the minds of industry and market leaders for the new year

95
article thumbnail

How FTC's noncompete agreements rule could impact healthcare

Fierce Healthcare

How FTC's noncompete agreements rule could impact healthcare. fdiamond. Fri, 01/06/2023 - 15:55

134
134
article thumbnail

The end-of-life care conundrum

Pharma Phorum

Research advises against aggressive cancer treatment at the end-of-life stages of the disease. At the same time, the pharmaceutical industry is creating a greater number of oncology treatments that could provide breakthroughs for patients where none previously existed.

article thumbnail

Study: Common Fatty Acid Contributes to Pain, Temperature Sensitivity in Psoriasis Plaques

Pharmacy Times

Results show an association between linoleic acid, found in nuts, seeds, and vegetable oils, and increased hypersensitivity in psoriatic lesions.

139
139
article thumbnail

Pfizer, GSK, AbbVie and many more celebrate New Year with price hikes: report

Fierce Pharma

Pfizer, GSK, AbbVie and many more celebrate New Year with price hikes: report. esagonowsky. Wed, 01/04/2023 - 10:21

119
119
article thumbnail

Carbon Health announces another round of layoffs, corporate restructuring amid challenging market conditions

Fierce Healthcare

Carbon Health announces another round of layoffs, corporate restructuring amid challenging market conditions. hlandi. Fri, 01/06/2023 - 20:01

130
130
article thumbnail

How decentralised storage networks can change the game for the pharmaceutical industry

Pharma Phorum

The way pharmaceutical companies manage data carries inherent risks, as exemplified by the constant scandals about data breaches. Is there anything that can be done about this?

article thumbnail

Utilizing Supportive Care in Patients with MDS

Pharmacy Times

A panel of medical experts discuss supportive care needs for patients with myelodysplastic syndrome.

139
139
article thumbnail

COVID-19 tracker: AstraZeneca workers who were fired for refusing vaccine file lawsuit

Fierce Pharma

COVID-19 tracker: AstraZeneca workers who were fired for refusing vaccine file lawsuit. kdunleavy. Tue, 01/03/2023 - 10:31

Vaccines 119
article thumbnail

Commonwealth Fund: Medicare inpatient spending concentrated among 2 systems in most regions

Fierce Healthcare

Commonwealth Fund: Medicare inpatient spending concentrated among 2 systems in most regions. rking. Thu, 01/05/2023 - 15:07

130
130
article thumbnail

pharmaphorum launches The World Without Disease Summit – June 2023

Pharma Phorum

pharmaphorum is proud to announce its inaugural “The World Without Disease Summit”: a high quality, two-day event bringing together key global leaders and innovators to explore the potential of disease interception in future health.

98
article thumbnail

Lifetime Weight Fluctuations May Predict Dementia Risk

Pharmacy Times

The overall trend of declining body mass index was associated with a higher risk of developing dementia.

139
139
article thumbnail

Cell therapies might revolutionise treatment for multiple sclerosis patients

Pharmaceutical Technology

While the treatment options for multiple sclerosis (MS) patients are growing each year with the approval of new agents, all of the currently marketed treatments only slow the disease’s progression and sometimes carry risks of severe side effects, such as liver failure or the development of viral infections.

115
115
article thumbnail

Northern Light Health inks strategic collaboration with Optum

Fierce Healthcare

Northern Light Health inks strategic collaboration with Optum. pminemyer. Thu, 01/05/2023 - 15:55

125
125
article thumbnail

Geron finally gets close to a product approval with imetelstat

Pharma Phorum

More than 30 years after it was first formed, Geron is on the cusp of bringing its first product to market, after imetelstat hit the mark in a phase 3 trial in patients with myelodysplastic syndromes (MDS).

98